期刊论文、会议论文

Clinical observation of compound Danshen drop pill preventing restenosis of patients with coronary heart disease after stenting operation

中文

现代中西医结合杂志

1008-8849

2010

19

8

920-921

复方丹参滴丸美国FDA II期临床试验结果报告暨第四届学术研讨会

复方丹参滴丸美国FDA II期临床试验结果报告暨第四届学术研讨会论文集

2010-08-01

天津

天津天士力集团

10.3969/j.issn.1008-8849.2010.08.005

本校为第一机构

目的:观察复方丹参滴丸预防冠心病支架术后再狭窄的临床效果。方法:80例成功接受冠脉内支架的冠心病患者随机分为对照组与治疗组，对照组给予常规疗法，治疗组在对照组基础上加用复方丹参滴丸。对2组患者随访观察6个月。结果:对照组心绞痛等主要临床症状发生率高于治疗组，治疗组再狭窄发生率明显低于对照组。结论:复方丹参滴丸对冠心病患者支架术后再狭窄有一定的预防作用。

Objective It is to observe the clinical effect of compound Danshen drop pill preventing restenosis of patients with coronary heart disease after stenting operation. Methods 80 patients with coronary heart disease who were successfully accepted stenting operation were randomly divided into control group and treatment group. The control group was treated with routine treatment. The treatment group was treated with compound Danshen drop pill based on the treatment of control group. The two groups were both followed up and observed for six months. Results The incidences of the main clinical sympto...